Resumen de acción CVS
CVS Health Corporation ofrece soluciones sanitarias en Estados Unidos.
| Puntuación del snowflake | |
|---|---|
| Valoración | 5/6 |
| Crecimiento futuro | 1/6 |
| Rendimiento pasado | 5/6 |
| Salud financiera | 2/6 |
| Dividendos | 6/6 |
Recompensas
Análisis de riesgos
Community Narratives
Narratives bring a range of perspectives from our community.
WA
WarrenAI
Based on Analyst Price Targets
Decisiveally Navigating Challenges For Enhanced Financial Health And Market Position
US$69.10
FV
15.0% undervalued intrinsic discount4.99%
Revenue growth p.a.
0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
about 1 month agoauthor updated this narrative
JU
julio
Community Contributor
CVS VALUATION
US$63.33
FV
7.2% undervalued intrinsic discount9.19%
Revenue growth p.a.
0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
about 2 months agoauthor updated this narrative
Competidores de CVS Health Corporation
Historial de precios y rendimiento
| Precios históricos de las acciones | |
|---|---|
| Precio actual de la acción | US$58.75 |
| Máximo en las últimas 52 semanas | US$83.25 |
| Mínimo de 52 semanas | US$52.77 |
| Beta | 0.51 |
| 1Cambio en 1 mes | -3.69% |
| Variación en 3 meses | 9.55% |
| Cambio de 1 año | -12.63% |
| 3Variación en 3 años | -30.56% |
| Variación en 5 años | -3.56% |
| Variación desde la OPV | 8,848.67% |
Noticias y actualizaciones recientes
A Piece Of The Puzzle Missing From CVS Health Corporation's (NYSE:CVS) Share Price
Aug 08
CVS Health Q2 Earnings: CEO's Swinging Axe May Have Ended The Bear Run
Aug 07Recent updates
A Piece Of The Puzzle Missing From CVS Health Corporation's (NYSE:CVS) Share Price
Aug 08CVS Health Q2 Earnings: CEO's Swinging Axe May Have Ended The Bear Run
Aug 07Here's Why CVS Health (NYSE:CVS) Has A Meaningful Debt Burden
Jul 21CVS Health: A Better Investment Than Walgreens Boots Alliance
Jul 09Vltava Fund - CVS Health Corp.: Why We Sold CVS
Jul 03CVS Health: Mismanagement, Eroding Moat And Poor Momentum Make It A Sell
Jun 21The Correct Play On CVS Health
Jun 06CVS Health: Downside Movement Is Overdramatic
May 26CVS Health: Secure Dividend And Upside Potential Presents Compelling Opportunity
May 15We Think Shareholders Are Less Likely To Approve A Pay Rise For CVS Health Corporation's (NYSE:CVS) CEO For Now
May 10CVS Health: A Terrible Earnings Report, But An Undervalued Stock
May 04CVS Health Corporation Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now
May 03CVS Health: 8x P/E, 8% Growth Projection - It's A Market Blind Spot
Apr 22Sentiment Still Eluding CVS Health Corporation (NYSE:CVS)
Apr 14CVS Health: Lookback, Management Guidance Vs. Results 2018-To-Date
Apr 10Does CVS Health (NYSE:CVS) Have A Healthy Balance Sheet?
Mar 27CVS Health: Better Times Likely Ahead
Mar 12CVS Health: Lower Guidance But Risk/Reward Remains Attractive
Feb 15CVS Health FY23 Earnings: Downgrades Inevitable, Long Term Outlook In The Balance
Feb 07CVS Health: Back In The Buy Column
Jan 21CVS Health (NYSE:CVS) Has Announced That It Will Be Increasing Its Dividend To $0.665
Jan 17CVS Health: Shares Remain Modestly Undervalued, Robust Free Cash Flow, Technical Strength
Jan 08CVS Health (NYSE:CVS) Is Paying Out A Larger Dividend Than Last Year
Jan 03CVS Health: Risk/Reward Highly Skewed To The Upside
Dec 15CVS Health (NYSE:CVS) Is Increasing Its Dividend To $0.665
Dec 13We Think CVS Health (NYSE:CVS) Is Taking Some Risk With Its Debt
Dec 08CVS Health: A Good Fit To Buffett's 10x Pretax Rule
Dec 07Rentabilidad de los accionistas
| CVS | US Healthcare | Mercado US | |
|---|---|---|---|
| 7D | -0.08% | 1.4% | 1.2% |
| 1Y | -12.6% | 14.1% | 25.9% |
Rentabilidad vs. Industria: Los resultados de CVS fueron inferiores a los de la industria US Healthcare, que obtuvo un rendimiento del 3.5% el año pasado.
Rentabilidad vs. Mercado: CVS obtuvo unos resultados inferiores a los del mercado US, que fueron del 22.3% el año pasado.
Volatilidad de los precios
| CVS volatility | |
|---|---|
| CVS Average Weekly Movement | 4.4% |
| Healthcare Industry Average Movement | 6.9% |
| Market Average Movement | 6.4% |
| 10% most volatile stocks in US Market | 15.2% |
| 10% least volatile stocks in US Market | 3.2% |
Precio estable de las acciones: CVS no ha tenido una volatilidad de precios significativa en los últimos 3 meses.
Volatilidad a lo largo del tiempo: La volatilidad semanal de CVS (6%) se ha mantenido estable durante el año pasado.
Acerca de la empresa
| Fundada | Empleados | CEO | Página web |
|---|---|---|---|
| 1996 | 259,500 | Karen Lynch | www.cvshealth.com |
CVS Health Corporation ofrece soluciones sanitarias en Estados Unidos. Opera a través de los segmentos Health Care Benefits, Health Services y Pharmacy & Consumer Wellness. El segmento Health Care Benefits ofrece productos de seguro médico tradicionales, voluntarios y dirigidos al consumidor, así como servicios relacionados.
Resumen de fundamentos de CVS Health Corporation
| Estadísticas fundamentales de CVS | |
|---|---|
| Capitalización bursátil | US$73.91b |
| Beneficios(TTM) | US$7.19b |
| Ingresos (TTM) | US$361.86b |
10.3x
Ratio precio-beneficio (PE)0.2x
Ratio precio-ventas (PS)¿Está CVS sobrevalorada?
Ver valor justo y análisis de valoraciónBeneficios e Ingresos
| Cuenta de resultados (TTM) de CVS | |
|---|---|
| Ingresos | US$361.86b |
| Coste de los ingresos | US$309.85b |
| Beneficio bruto | US$52.00b |
| Otros gastos | US$44.81b |
| Beneficios | US$7.19b |
Últimos beneficios comunicados
Jun 30, 2024
Próxima fecha de beneficios
Nov 06, 2024
| Beneficios por acción (BPA) | 5.72 |
| Margen bruto | 14.37% |
| Margen de beneficio neto | 1.99% |
| Ratio deuda/patrimonio | 86.5% |
¿Cómo se ha desempeñado CVS a largo plazo?
Ver rendimiento histórico y comparativa